For research use only
| Cat No. | ABC-X0066C |
| Product Type | Overexpression Stable Cell Lines |
| Cell Type | Lymphocytes |
| Species | Human |
| Host Cell | BAF3 |
| Source Organ | Lymphatic |
| Disease | Normal |
| Storage | Liquid Nitrogen |
This cell line expressing SLC34A2-ROS1 (D2113G) enables modeling of oncogenic ROS1 variants and facilitates precision drug development research.
The Human SLC34A2_ROS1 (D2113G) BAF3 Cell Line is a genetically engineered model derived from the murine pro-B cell line BAF3 based on customers’ requirement. This overexpression cell line is generated by stable integration of exogenous human SLC34A2_ROS1 (D2113G) fusion gene into BAF3 host cells using our optimized transduction of lentiviral vectors. Overexpression clone is validated at gene level by qRT-PCR.
Target
The SLC34A2_ROS1 (D2113G) fusion involves a solute carrier protein and the receptor tyrosine kinase ROS1, with a D2113G mutation. This alteration is linked to constitutive ROS1 activation, driving oncogenic pathways such as PI3K/AKT and MAPK. ROS1 fusions are key therapeutic targets in non-small cell lung cancer. AcceGen offers generation of stable overexpression cell lines targeting any gene of your interest. Polyclonal or monoclonal is optional based on customers’ research needs.
| Species | Human |
| Cat.No | ABC-X0066C |
| Product Category | Transfected Stable Cell Lines |
| Size/Quantity | 1 vial |
| Cell Type | Lymphocytes |
| Growth Mode | Suspension |
| Shipping Info | Dry Ice |
| Growth Conditions | 37 °C, 5% CO2 |
| Source Organ | Lymphatic |
| Disease | Normal |
| Biosafety Level | 1 |
| Storage | Liquid Nitrogen |
| Product Type | Overexpression Stable Cell Lines |
| Host Cell | BAF3 |
| Quality Control | All cells test negative for mycoplasma, bacteria, yeast, and fungi. |
The Human SLC34A2_ROS1 (D2113G) BAF3 Cell Line supports investigation of ROS1 mutation-mediated oncogenesis and facilitates development of ROS1-targeted inhibitors. It provides a robust system for resistance modeling and drug efficacy testing.